uBriGene

Beijing, Beijing, China

http://www.ubrigene.com

Company profile

uBriGene company profile

Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization.

Business identity

Website: http://www.ubrigene.com
Operating status: Active
Company type: For Profit
Employee range: 00501-01000 employees
Founded: 2015-01-01

Headquarters

Headquarters: Beijing, Beijing, China
Country code: CN
Continent: Asia

Capital profile

Funding and company signals

Funding stage: Late Stage Venture
Funding rounds: 5
Total equity funding: $94.8M
Last funding: Series D / $27.4M / 2024-12-24
Last equity funding: Series D / $27.4M
Investors: 18
Lead investors: 4
Founders: 1
Articles: 7

Categories and groups

Biotechnology Biotechnology Science and Engineering

Founders and investors

Founders

Qichen Li

Lead investors

CLSAGuotai Junan Innovation InvestmentJinan Industrial Development GroupJinshi Investment

Investors

Addor CapitalCowin CapitalGuotai Junan Innovation InvestmentHuagai CapitalIDG Capital

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.